Optceutics Limited
Research - London, England, United Kingdom
Optceutics Limited Employees
Optceutics Limited Details
Optceutics Ltd has developed an innovative ocular model (PK-Eye) to accelerate ophthalmic drug development of protein-based and small molecules for the posterior segment of the eye. The PK-Eye is a two-compartment model that mimics the dimensions, mass transfer, aqueous outflow and clearance from the posterior segment. It has shown utility for (i) the rapid and accurate evaluation of proprietary third party formulations and (ii) accelerating pre-formulation studies for new intraocular medicines. The PK-Eye is used to potentially avoid non-human primate studies (especially for biosimilar development) and to design clinical protocols at the most appropriate dose areparamount for clinical development.
Optceutics Limited Technologies
Email Providers
Outlook
Load Balancers
Varnish
CMS
Wix
Other
Mobile Friendly